Publications by authors named "Gary Disbrow"

Claim this Profile
B
Building a Fast Response Capability for Emerging Infectious Diseases Within the Biomedical Advanced Research and Development Authority.
Robert A Johnson, Terence M Barnhart, Gary L Disbrow

Health Secur· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Project NextGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future.
Kimberly A Hofmeyer, Christy L Ventura, Kimberly L Armstrong, Christopher R Houchens, Sandeep Patel, Gary L Disbrow

Clin Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Global Collaboration Can Improve the Medical Countermeasure Life Cycle for Infectious Disease Outbreaks.
Jessica Swenson, Gary Disbrow, Robert A Johnson

J Infect Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing development of medical countermeasures: Incorporating COVID-19 lessons learned into future pandemic preparedness planning.
Robert A Johnson, Richard C White, Gary L Disbrow

Hum Vaccin Immunother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sepsis Among Medicare Beneficiaries: 4. Precoronavirus Disease 2019 Update January 2012-February 2020.
Charles E Frank, Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, George E Plopper, Gary L Disbrow

Crit Care Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries.
Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, Kristen P Finne, Nicole Sowers, Gary L Disbrow

Vaccine· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012-2018.
Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, Kristen P Finne, Nicole Sowers, Gary L Disbrow

Crit Care Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012-2018.
Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, Kristen P Finne, Nicole Sowers, Gary L Disbrow

Crit Care Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012-2018.
Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, Kristen P Finne, Nicole Sowers, Gary L Disbrow

Crit Care Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress towards a vaccine against Ebola to meet emergency medical countermeasure needs.
Daniel N Wolfe, Amanda G Zarrabian, Gary L Disbrow, Eric M Espeland

Vaccine· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks.
Eric M Espeland, Chia-Wei Tsai, Joseph Larsen, Gary L Disbrow

PLoS Negl Trop Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Project BioShield and the Biomedical Advanced Research Development Authority: A ten year progress report on meeting U.S. preparedness objectives for threat agents.
Joseph C Larsen, Gary L Disbrow

Clin Infect Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The U.S. government's medical countermeasure portfolio management for nuclear and radiological emergencies: synergy from interagency cooperation.
Marcy B Grace, Kenneth D Cliffer, Brian R Moyer, C Norman Coleman, Joanna M Prasher, Gary L Disbrow

Health Phys· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant.
Clare A Thibodeaux, Xuefeng Liu, Gary L Disbrow, Yiyu Zhang, Janice D Rone

Breast Cancer Res Treat· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.
Xuefeng Liu, Aleksandra Dakic, Renxiang Chen, Gary L Disbrow, Yiyu Zhang

J Virol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.
Xuefeng Liu, Gary L Disbrow, Hang Yuan, Vjekoslav Tomaic, Richard Schlegel

J Virol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo.
Gary L Disbrow, Astrid C Baege, Katie A Kierpiec, Hang Yuan, Jose A Centeno

Cancer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene.
Sybil M Genther Williams, Gary L Disbrow, Richard Schlegel, Daekee Lee, David W Threadgill

Cancer Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH.
Gary L Disbrow, John A Hanover, Richard Schlegel

J Virol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.
Xuefeng Liu, Hang Yuan, Baojin Fu, Gary L Disbrow, Tania Apolinario

J Biol Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16?
Frank A Suprynowicz, Gary L Disbrow, Vera Simic, Richard Schlegel

Virology· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesis.
Astrid C Baege, Gary L Disbrow, Richard Schlegel

J Virol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Codon optimization of the HPV-16 E5 gene enhances protein expression.
Gary L Disbrow, Iruvanti Sunitha, Carl C Baker, John Hanover, Richard Schlegel

Virology· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins.
Allison J Berger, Astrid Baege, Tracy Guillemette, James Deeds, Ron Meyer, Gary Disbrow

Am J Pathol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis